Abstract
In 2006, this market generated over $380 million in revenues.
The US gynecological device market, comprises global endometrial ablation
(GEA), female sterilization, uterine artery embolization (UAE), hysteroscopes,
assisted reproduction consumables (ARC), colposcopes, fluid management, and
endometrial resection.